106 related articles for article (PubMed ID: 38863829)
1. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
2. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
Wang M; Zhang Y; Li C; Chang W; Zhang L
Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
[TBL] [Abstract][Full Text] [Related]
3. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
Din AU; Mazhar M; Waseem M; Ahmad W; Bibi A; Hassan A; Ali N; Gang W; Qian G; Ullah R; Shah T; Ullah M; Khan I; Nisar MF; Wu J
Biomed Pharmacother; 2021 Jan; 133():110947. PubMed ID: 33197765
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Chattopadhyay I; Shankar EM
Front Cell Infect Microbiol; 2021; 11():590874. PubMed ID: 33791231
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
7. Probiotics and Coronavirus disease 2019: think about the link.
Angurana SK; Bansal A
Br J Nutr; 2021 Nov; 126(10):1564-1570. PubMed ID: 32921328
[TBL] [Abstract][Full Text] [Related]
8. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity and COVID-19 - The microbiotal connection.
Katz-Agranov N; Zandman-Goddard G
Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
[TBL] [Abstract][Full Text] [Related]
11. Probiotics and Covid-19.
Bottari B; Castellone V; Neviani E
Int J Food Sci Nutr; 2021 May; 72(3):293-299. PubMed ID: 32787470
[TBL] [Abstract][Full Text] [Related]
12. The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic.
Lee E; Hong SJ
Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):245-251. PubMed ID: 33769313
[TBL] [Abstract][Full Text] [Related]
13. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection.
Spagnolello O; Pinacchio C; Santinelli L; Vassalini P; Innocenti GP; De Girolamo G; Fabris S; Giovanetti M; Angeletti S; Russo A; Mastroianni CM; Ciccozzi M; Ceccarelli G; d'Ettorre G
Chemotherapy; 2021; 66(1-2):24-32. PubMed ID: 33756475
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between immune system and microbiota in COVID-19.
Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
[TBL] [Abstract][Full Text] [Related]
15. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
16. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
Viruses; 2023 May; 15(6):. PubMed ID: 37376531
[TBL] [Abstract][Full Text] [Related]
19. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.
Chakraborty C; Sharma AR; Bhattacharya M; Dhama K; Lee SS
World J Gastroenterol; 2022 Jul; 28(25):2802-2822. PubMed ID: 35978881
[TBL] [Abstract][Full Text] [Related]
20. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]